Zeno Equity Partners LLP Buys 6,856 Shares of Danaher Corporation $DHR

Zeno Equity Partners LLP lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 2.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 265,795 shares of the conglomerate’s stock after buying an additional 6,856 shares during the quarter. Danaher comprises about 24.5% of Zeno Equity Partners LLP’s holdings, making the stock its biggest holding. Zeno Equity Partners LLP’s holdings in Danaher were worth $52,756,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of DHR. Ellerson Group Inc. ADV raised its stake in Danaher by 0.8% during the 3rd quarter. Ellerson Group Inc. ADV now owns 14,292 shares of the conglomerate’s stock worth $2,834,000 after acquiring an additional 107 shares in the last quarter. Lansforsakringar Fondforvaltning AB publ grew its holdings in shares of Danaher by 1.6% during the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 201,296 shares of the conglomerate’s stock worth $39,909,000 after purchasing an additional 3,244 shares during the last quarter. Advyzon Investment Management LLC increased its position in shares of Danaher by 17.1% during the third quarter. Advyzon Investment Management LLC now owns 2,051 shares of the conglomerate’s stock worth $407,000 after purchasing an additional 300 shares in the last quarter. HFR Wealth Management LLC increased its position in shares of Danaher by 1.9% during the third quarter. HFR Wealth Management LLC now owns 42,504 shares of the conglomerate’s stock worth $8,427,000 after purchasing an additional 773 shares in the last quarter. Finally, ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher in the 3rd quarter valued at about $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on DHR shares. JPMorgan Chase & Co. raised their price target on Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Jefferies Financial Group lifted their target price on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. KeyCorp reiterated an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Morgan Stanley started coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective on the stock. Finally, Wells Fargo & Company lifted their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Twenty equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

Danaher Stock Performance

Shares of DHR opened at $209.56 on Friday. The stock has a market capitalization of $148.02 billion, a P/E ratio of 41.58, a P/E/G ratio of 2.83 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $242.80. The company’s fifty day moving average is $226.85 and its two-hundred day moving average is $215.89.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. During the same quarter last year, the business earned $2.14 EPS. The business’s revenue was up 4.6% on a year-over-year basis. On average, sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s payout ratio is currently 25.40%.

Insider Transactions at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.